133 related articles for article (PubMed ID: 10380908)
1. Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily.
Banham AH; Colonna M; Cella M; Micklem KJ; Pulford K; Willis AC; Mason DY
J Leukoc Biol; 1999 Jun; 65(6):841-5. PubMed ID: 10380908
[TBL] [Abstract][Full Text] [Related]
2. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions.
Saverino D; Fabbi M; Ghiotto F; Merlo A; Bruno S; Zarcone D; Tenca C; Tiso M; Santoro G; Anastasi G; Cosman D; Grossi CE; Ciccone E
J Immunol; 2000 Oct; 165(7):3742-55. PubMed ID: 11034379
[TBL] [Abstract][Full Text] [Related]
3. CD85/LIR-1/ILT2 and CD152 (cytotoxic T lymphocyte antigen 4) inhibitory molecules down-regulate the cytolytic activity of human CD4+ T-cell clones specific for Mycobacterium tuberculosis.
Merlo A; Saverino D; Tenca C; Grossi CE; Bruno S; Ciccone E
Infect Immun; 2001 Oct; 69(10):6022-9. PubMed ID: 11553539
[TBL] [Abstract][Full Text] [Related]
4. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells.
Saverino D; Merlo A; Bruno S; Pistoia V; Grossi CE; Ciccone E
J Immunol; 2002 Jan; 168(1):207-15. PubMed ID: 11751964
[TBL] [Abstract][Full Text] [Related]
5. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells.
Colonna M; Navarro F; Bellón T; Llano M; García P; Samaridis J; Angman L; Cella M; López-Botet M
J Exp Med; 1997 Dec; 186(11):1809-18. PubMed ID: 9382880
[TBL] [Abstract][Full Text] [Related]
6. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.
Shiroishi M; Tsumoto K; Amano K; Shirakihara Y; Colonna M; Braud VM; Allan DS; Makadzange A; Rowland-Jones S; Willcox B; Jones EY; van der Merwe PA; Kumagai I; Maenaka K
Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8856-61. PubMed ID: 12853576
[TBL] [Abstract][Full Text] [Related]
7. Genetic variability of the major histocompatibility complex class I homologue encoded by human cytomegalovirus leads to differential binding to the inhibitory receptor ILT2.
Valés-Gómez M; Shiroishi M; Maenaka K; Reyburn HT
J Virol; 2005 Feb; 79(4):2251-60. PubMed ID: 15681427
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
Harly C; Peyrat MA; Netzer S; Déchanet-Merville J; Bonneville M; Scotet E
Blood; 2011 Mar; 117(10):2864-73. PubMed ID: 21233315
[TBL] [Abstract][Full Text] [Related]
9. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function.
Liang S; Zhang W; Horuzsko A
Eur J Immunol; 2006 Sep; 36(9):2457-71. PubMed ID: 16897816
[TBL] [Abstract][Full Text] [Related]
10. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization.
Dietrich J; Cella M; Colonna M
J Immunol; 2001 Feb; 166(4):2514-21. PubMed ID: 11160312
[TBL] [Abstract][Full Text] [Related]
11. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL.
Young NT; Uhrberg M; Phillips JH; Lanier LL; Parham P
J Immunol; 2001 Mar; 166(6):3933-41. PubMed ID: 11238638
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine nitration in the human leucocyte antigen-G-binding domain of the Ig-like transcript 2 protein.
Díaz-Lagares A; Alegre E; Arroyo A; Corrales FJ; González A
FEBS J; 2009 Aug; 276(15):4233-43. PubMed ID: 19583775
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory and activating receptors involved in immune surveillance by human NK and myeloid cells.
Colonna M; Nakajima H; Cella M
J Leukoc Biol; 1999 Nov; 66(5):718-22. PubMed ID: 10577499
[TBL] [Abstract][Full Text] [Related]
15. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells.
Navarro F; Llano M; Bellón T; Colonna M; Geraghty DE; López-Botet M
Eur J Immunol; 1999 Jan; 29(1):277-83. PubMed ID: 9933109
[TBL] [Abstract][Full Text] [Related]
16. Cis association of leukocyte Ig-like receptor 1 with MHC class I modulates accessibility to antibodies and HCMV UL18.
Li NL; Fu L; Uchtenhagen H; Achour A; Burshtyn DN
Eur J Immunol; 2013 Apr; 43(4):1042-52. PubMed ID: 23348966
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of natural killer cell surface receptors.
Radaev S; Sun PD
Annu Rev Biophys Biomol Struct; 2003; 32():93-114. PubMed ID: 12471063
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of ILT family receptors.
Nakajima H; Asai A; Okada A; Ping L; Hamajima F; Sata T; Isobe K
J Immunol; 2003 Dec; 171(12):6611-20. PubMed ID: 14662864
[TBL] [Abstract][Full Text] [Related]
19. High expression of the ILT2 (LIR-1) inhibitory receptor for major histocompatibility complex class I molecules on clonal expansions of T large granular lymphocytes in asymptomatic patients.
Casado LF; Granados E; Algara P; Navarro F; Martinez-Frejo MC; López-Botet M
Haematologica; 2001 May; 86(5):457-63. PubMed ID: 11410407
[TBL] [Abstract][Full Text] [Related]
20. High affinity soluble ILT2 receptor: a potent inhibitor of CD8(+) T cell activation.
Moysey RK; Li Y; Paston SJ; Baston EE; Sami MS; Cameron BJ; Gavarret J; Todorov P; Vuidepot A; Dunn SM; Pumphrey NJ; Adams KJ; Yuan F; Dennis RE; Sutton DH; Johnson AD; Brewer JE; Ashfield R; Lissin NM; Jakobsen BK
Protein Cell; 2010 Dec; 1(12):1118-27. PubMed ID: 21213105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]